DE69527203T2 - Wirkstoff zur stimulation von hartem gewebe - Google Patents

Wirkstoff zur stimulation von hartem gewebe

Info

Publication number
DE69527203T2
DE69527203T2 DE69527203T DE69527203T DE69527203T2 DE 69527203 T2 DE69527203 T2 DE 69527203T2 DE 69527203 T DE69527203 T DE 69527203T DE 69527203 T DE69527203 T DE 69527203T DE 69527203 T2 DE69527203 T2 DE 69527203T2
Authority
DE
Germany
Prior art keywords
hard tissue
pct
active substance
stimulating
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69527203T
Other languages
English (en)
Other versions
DE69527203D1 (de
Inventor
Hans-Arne Hansson
Gunilla Johansson-Ruden
Olle Larm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medicarb AB
Original Assignee
Medicarb AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicarb AB filed Critical Medicarb AB
Application granted granted Critical
Publication of DE69527203D1 publication Critical patent/DE69527203D1/de
Publication of DE69527203T2 publication Critical patent/DE69527203T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE69527203T 1994-07-19 1995-07-13 Wirkstoff zur stimulation von hartem gewebe Expired - Lifetime DE69527203T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9402528A SE9402528D0 (sv) 1994-07-19 1994-07-19 Hårdvävnadsstimulerande med el
PCT/SE1995/000857 WO1996002259A1 (en) 1994-07-19 1995-07-13 Hard tissue stimulating agent

Publications (2)

Publication Number Publication Date
DE69527203D1 DE69527203D1 (de) 2002-08-01
DE69527203T2 true DE69527203T2 (de) 2003-01-09

Family

ID=20394768

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69527203T Expired - Lifetime DE69527203T2 (de) 1994-07-19 1995-07-13 Wirkstoff zur stimulation von hartem gewebe

Country Status (22)

Country Link
US (1) US5894070A (de)
EP (1) EP0771206B1 (de)
JP (1) JP3492377B2 (de)
KR (1) KR100395724B1 (de)
CN (1) CN1081923C (de)
AT (1) ATE219678T1 (de)
BR (1) BR9508322A (de)
CA (1) CA2194462C (de)
CZ (1) CZ289981B6 (de)
DE (1) DE69527203T2 (de)
DK (1) DK0771206T3 (de)
ES (1) ES2178675T3 (de)
FI (1) FI970202A (de)
HU (1) HU220770B1 (de)
IS (1) IS1793B (de)
MX (1) MX9700443A (de)
NO (1) NO310223B1 (de)
NZ (1) NZ290219A (de)
PL (1) PL181764B1 (de)
RU (1) RU2153877C2 (de)
SE (1) SE9402528D0 (de)
WO (1) WO1996002259A1 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9402528D0 (sv) * 1994-07-19 1994-07-19 Astra Ab Hårdvävnadsstimulerande med el
KR100237738B1 (ko) * 1997-04-26 2000-01-15 이용찬 생채 매식용 의료기구 임플란트의 기능 향상방법
DE19724869C2 (de) * 1997-06-12 1999-05-12 Henkel Kgaa Verwendung von Citosanderivaten zur Oberflächenbeschichtung
DE69809158T2 (de) * 1997-08-28 2003-03-20 Ngk Spark Plug Co Calciumphosphatzement und Calciumphosphatzementzusammensetzung
JP4215884B2 (ja) * 1998-03-23 2009-01-28 日本特殊陶業株式会社 リン酸カルシウムセメント及びリン酸カルシウムセメント組成物
US20030147860A1 (en) * 2002-02-07 2003-08-07 Marchosky J. Alexander Compositions and methods for forming and strengthening bone
US6263880B1 (en) 1998-06-22 2001-07-24 Neovasys, Inc. Method of enhancing blood flow in tissue
EP1152013B1 (de) * 1998-11-10 2008-04-23 Netech Inc. Funktionelle chitosanderivate
FR2791262B1 (fr) * 1999-03-22 2001-09-28 Virbac Sa Compositions a base de chondroitine et de chitosan pour la protection, le traitement ou le remplacement des tissus conjonctifs
WO2001000792A1 (en) 1999-06-29 2001-01-04 Marchosky J Alexander Compositions and methods for forming and strengthening bone
GB9920393D0 (en) * 1999-08-27 1999-11-03 Medix Scient Uk Limited Plant extract mixtures and their uses
FI19991852A (fi) 1999-09-01 2001-03-01 Yli Urpo Antti Uusi monikerroksinen materiaali, joka käsittää vaikuttavan ainesosan, ja sen valmistus
ES2491866T3 (es) * 1999-11-15 2014-09-08 Piramal Healthcare (Canada) Limited Disolución biopolimérica acuosa autogelificante controlada por la temperatura y dependiente del pH
US20030158302A1 (en) * 1999-12-09 2003-08-21 Cyric Chaput Mineral-polymer hybrid composition
ATE243049T1 (de) * 1999-12-09 2003-07-15 Biosyntech Canada Inc Mineral-polymer hybrid-zusammensetzung
DK1294414T3 (da) * 2000-06-29 2006-07-24 Biosyntech Canada Inc Præparat og fremgangsmåde til heling og regenerering af brusk og andre væv
ES2169681B1 (es) * 2000-08-10 2003-10-01 Osfarma S L Metodo de produccion de filmes de quitosan con una alta capacidad de adherencia celular, producto obrenido y aplicaciones.
US20040091540A1 (en) * 2000-11-15 2004-05-13 Desrosiers Eric Andre Method for restoring a damaged or degenerated intervertebral disc
CA2493083C (en) * 2002-07-16 2012-11-06 Bio Syntech Canada Inc. Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors
US20040054414A1 (en) 2002-09-18 2004-03-18 Trieu Hai H. Collagen-based materials and methods for augmenting intervertebral discs
FR2844717B1 (fr) * 2002-09-23 2006-07-07 Richard Cancel Plaque de renfort comprenant notamment du chitosane
CN100394989C (zh) * 2002-11-15 2008-06-18 华沙整形外科股份有限公司 包含微粒状基于胶原材料的组合物的制药应用和包含所述组合物的滑膜关节
US20040186471A1 (en) * 2002-12-07 2004-09-23 Sdgi Holdings, Inc. Method and apparatus for intervertebral disc expansion
DE10338110A1 (de) * 2003-08-15 2005-03-10 Biomet Deutschland Gmbh Mit Chitosan beschichteter metallischer Gegenstand sowie Verfahren zu dessen Herstellung
WO2005065396A2 (en) * 2003-12-31 2005-07-21 Osteotech, Inc. Improved bone matrix compositions and methods
US20070231788A1 (en) * 2003-12-31 2007-10-04 Keyvan Behnam Method for In Vitro Assay of Demineralized Bone Matrix
FR2866571B1 (fr) * 2004-02-20 2007-09-21 Philippe Zanchetta Utilisation d'un melange de polysaccharides specifiques denomme par l'inventeur ezbone, comprenant de l'acide hyaluronique, de la chondroitine 6 sulfate, du dermatane sulfate et de l'heparine en cicatrisation osseuse.
NZ551771A (en) * 2004-05-07 2009-06-26 Univ Queensland Composition for stimulating bone growth and differentiation and method for isolating same
AU2005239977B2 (en) * 2004-05-07 2010-11-11 The University Of Queensland Composition for stimulating bone growth and differentiation and method for isolating same
DK1789534T3 (en) 2004-08-16 2014-11-17 Cellres Corp Pte Ltd ISOLATION OF stem / progenitor cells FOSTER HINDE FROM an umbilical cord
WO2006078211A1 (en) * 2005-01-19 2006-07-27 Bonoss Medical Ab Growth factor composition
CN101330935B (zh) 2005-10-21 2013-11-13 细胞研究私人有限公司 自脐带羊膜分离和培养干/祖细胞及其分化的细胞的应用
US8911759B2 (en) * 2005-11-01 2014-12-16 Warsaw Orthopedic, Inc. Bone matrix compositions and methods
WO2007051311A1 (en) * 2005-11-04 2007-05-10 Bio Syntech Canada Inc. Gel formation of polyelectrolyte aqueous solutions by thermally induced changes in ionization state
DE102006020035A1 (de) * 2006-04-26 2007-10-31 B. Braun Melsungen Ag Herstellung und Verwendung von Poly(hydroxyethylstärke)chitin- und Poly(Carboxymethylstärke)chitin-Verbindungen
US8399619B2 (en) * 2006-06-30 2013-03-19 Warsaw Orthopedic, Inc. Injectable collagen material
US8118779B2 (en) * 2006-06-30 2012-02-21 Warsaw Orthopedic, Inc. Collagen delivery device
EP1977739A1 (de) * 2007-04-03 2008-10-08 Bioiberica, S.A. Nanoteilchenförmige Zusammensetzung von Chitosan und Chondroitinsulfat
US8642061B2 (en) * 2007-06-15 2014-02-04 Warsaw Orthopedic, Inc. Method of treating bone tissue
US9554920B2 (en) * 2007-06-15 2017-01-31 Warsaw Orthopedic, Inc. Bone matrix compositions having nanoscale textured surfaces
WO2008157495A2 (en) * 2007-06-15 2008-12-24 Osteotech, Inc. Bone matrix compositions and methods
WO2008157492A2 (en) 2007-06-15 2008-12-24 Osteotech, Inc. Osteoinductive demineralized cancellous bone
US9492278B2 (en) * 2007-07-10 2016-11-15 Warsaw Orthopedic, Inc. Delivery system
US20110054408A1 (en) * 2007-07-10 2011-03-03 Guobao Wei Delivery systems, devices, tools, and methods of use
ES2446544T3 (es) 2007-10-19 2014-03-10 Warsaw Orthopedic, Inc. Composiciones de matrices óseas desmineralizadas y métodos
GB2463474B (en) 2008-09-11 2012-05-02 Agency Science Tech & Res Therapeutic bone growth and regeneration
US9101475B2 (en) * 2009-02-12 2015-08-11 Warsaw Orthopedic, Inc. Segmented delivery system
KR20140120316A (ko) 2012-01-27 2014-10-13 에프. 호프만-라 로슈 아게 표적화된 전달을 위한 소분자 인테그린 안타고니스트와 공유 결합된 키토산
EP3569262A1 (de) 2013-03-14 2019-11-20 Tricol Biomedical, Inc. Bioverträgliche und bioabsorbierbare derivatisierte chitosanzusammensetzungen
CN105126165B (zh) * 2015-01-21 2017-12-08 中国人民解放军第三〇七医院 一种钛牙种植体材料及其制备方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL163522B (nl) * 1970-07-20 1980-04-15 Montedison Spa Werkwijze om een katalysator te bereiden voor de polymerisatie van alkenen-1.
US5510418A (en) * 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
US5256447A (en) * 1991-12-31 1993-10-26 Minnesota Mining And Manufacturing Company Adhesive composition and method
CA2117347A1 (en) * 1991-12-31 1993-07-08 Joel D. Oxman Metal filled adhesive composition and method
SE9402528D0 (sv) * 1994-07-19 1994-07-19 Astra Ab Hårdvävnadsstimulerande med el

Also Published As

Publication number Publication date
HU220770B1 (hu) 2002-05-28
NO970215D0 (no) 1997-01-17
EP0771206A1 (de) 1997-05-07
FI970202A0 (fi) 1997-01-17
MX9700443A (es) 1997-04-30
FI970202A (fi) 1997-01-17
CN1081923C (zh) 2002-04-03
NO970215L (no) 1997-01-17
AU3089595A (en) 1996-02-16
IS4409A (is) 1997-01-06
IS1793B (is) 2001-12-12
US5894070A (en) 1999-04-13
NZ290219A (en) 1998-06-26
KR100395724B1 (ko) 2004-02-18
CA2194462C (en) 2007-07-10
PL181764B1 (pl) 2001-09-28
KR970704459A (ko) 1997-09-06
HUT77607A (hu) 1998-06-29
HU9700160D0 (en) 1997-03-28
NO310223B1 (no) 2001-06-11
CA2194462A1 (en) 1996-02-01
CZ289981B6 (cs) 2002-05-15
CZ14097A3 (en) 1997-07-16
BR9508322A (pt) 1998-01-06
ATE219678T1 (de) 2002-07-15
CN1157568A (zh) 1997-08-20
DK0771206T3 (da) 2002-08-19
PL318326A1 (en) 1997-06-09
SE9402528D0 (sv) 1994-07-19
EP0771206B1 (de) 2002-06-26
RU2153877C2 (ru) 2000-08-10
JPH10502664A (ja) 1998-03-10
AU696183B2 (en) 1998-09-03
ES2178675T3 (es) 2003-01-01
WO1996002259A1 (en) 1996-02-01
DE69527203D1 (de) 2002-08-01
JP3492377B2 (ja) 2004-02-03

Similar Documents

Publication Publication Date Title
DE69527203D1 (de) Wirkstoff zur stimulation von hartem gewebe
RU97102352A (ru) Агент, стимулирующий твердую ткань
NO924697D0 (no) Kirurgisk implantat og en fremgangsmaate for behandling avkirurgisk implantat
KR100381207B1 (de)
ATE237285T1 (de) Medizinisches implantat
AU6788694A (en) Use of particles of a biocompatible, bioabsorbable calcium salt as active principle in the preparation of a medicament for local treatment of bone demineralizing diseases
DE69943067D1 (de) Verwendung von dreidimensionalen Prothesen, die Hyaluronsäurederivate enthalten
ES2180649T3 (es) Agente antiadherente.
ATE368455T1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
MX9603619A (es) Microparticulas que contienen gas, medios que contienen el ultimo, su uso en diagnosis ultrasonica, tambien como procesos para la produccion de las particulas y los medios.
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
MD899G2 (ro) Procedeu de activizare a osteogenezei reparatorii
UA23896A (uk) Спосіб лікування зламів нижньої щелепи із сповільненою консолідацією
RU2000103476A (ru) Способ лечения больных с нарушениями консолидации переломов длинных костей конечностей
UA12438A (uk) Спосіб відділеhhя зоhи впливу hа пацієhта від оточуючого простору та пристрій для здійсhеhhя способу
UA32173A (uk) Спосіб лікування недорозвиненої середньої зони лицевого скелету

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: MEDICARB AB, BROMMA, SE